James Meckstroth

James Meckstroth is a senior quality assurance executive with more than 25 years of leadership experience in FDA-regulated GxP environments across commercial manufacturing and clinical research. He provides strategic oversight for global compliance service teams encompassing Global Auditing, AI/ML Governance, and Clinical Quality. He is recognized for his expertise in global regulatory compliance and quality systems, with deep knowledge of FDA, EMA, ICH, GCP, and GMP standards. Mr. Meckstroth has successfully led organizations through FDA general and pre-approval inspections and has extensive experience managing regulatory interactions, enterprise audit programs, and independent Data and Safety Monitoring Boards. His leadership focuses on building and optimizing Quality Management Systems (QMS), advancing risk-based quality strategies, and strengthening inspection readiness and remediation at scale. He brings a strong track record in governance, vendor oversight, CAPA, and complex deviation and OOS investigations, as well as operational excellence through process optimization and organizational capability building. Mr. Meckstroth has broad product and manufacturing experience, including small molecule and potent/cytotoxic compounds in both sterile and non-sterile environments. He holds a B.S. in Microbiology from The University of Kansas and a Master of Business Administration from Avila University.